EUVIMEDEUVIMED entdecken
Open Access

Neuronal Surface and Intracellular Antibodies in Mild Cognitive Impairment Due to Alzheimer Disease: Preserved Brain Metabolism on 18 F-FDG-PET

Heya Luan, Zhigeng Chen iD, Xiaodong Han, Pin Wang, Wenxian Sun, Jin Gong, Shaoqi Li, Ruina Li, Chang Xu, Boye Wen, Sirong Lv, Shaozhen Yan und 1 weitere

American Journal of Neuroradiology · 2026

DOI: 10.3174/ajnr.a9159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Neuroradiology, 2026. Verfasst von Heya Luan und 12 weiteren Autor:innen. Beteiligte Einrichtung: From the Innovation Center for Neurological Disorders and Department of Neurology (H.L., X.H., P.W., W.S., C.X., B.W., S. Lv, C.W.), Xuanwu Hospital,…. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron-Emission Tomography, Cognitive Dysfunction, Alzheimer Disease. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: STI2030-Major Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND PURPOSE: Neuronal autoantibodies, which can mediate pathogenic mechanism in autoimmune encephalitis, are increasingly observed in mild cognitive impairment (MCI), yet their diagnostic or phenotypic implications in neurodegeneration remain unclear. This study aimed to evaluate the clinical and neuroimaging characteristics of antibody-positive MCI. MATERIALS AND METHODS: This cross-sectional study included 97 patients diagnosed with MCI. Antibody was assessed by cell-based assays in both CSF and serum. Clinical features were systematically compared between antibody-positive and antibody-negative groups. Semiquantitative analyses of 18F-FDG-PET and 11C-Pittsburgh compound B (11C-PIB)-PET were performed among 20 amyloid-positive patients with MCI. All images underwent standardized preprocessing, with standardized uptake value ratios calculated using cerebellar gray matter as reference. Group-wise differences of whole-brain and ROI analyses (frontal, parietal, temporal, occipital lobes) were analyzed. RESULTS: Neuronal antibodies were detected in 10 patients (10.3%), including anti-GABABR (n=1), anti-SOX-1 (n=3), anti-Ri (n=3), anti-Titin (n=3), and anti-Amphiphysin (n=1). Clinical profiles were highly comparable between groups; antibody-positive patients only demonstrated significantly higher abnormal tumor markers (P = .014). Compared with the antibody-negative group, the antibody-positive group exhibited relatively preserved metabolism on 18F-FDG-PET (P = .035), predominantly in the right parietal lobe (P = .030). Further subregion analysis identified the right postcentral gyrus and supramarginal gyrus as focal hubs. No significant group differences were observed on 11C-PIB-PET. CONCLUSIONS: Antibody-positive MCI showed relatively preserved metabolism on 18F-FDG-PET, despite indistinguishable clinical features. Identification of the antibody-positive group may provide novel insights into possible antibody-mediated pathogenesis in neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Positron-Emission TomographyCognitive DysfunctionAlzheimer DiseaseBrainAutoantibodiesNeuronsHumansFemaleMaleAgedRadiopharmaceuticalsCross-Sectional StudiesAniline CompoundsThiazolesMiddle AgedAged, 80 and over

Substanzen

Fluorodeoxyglucose F18RadiopharmaceuticalsAutoantibodiesAniline CompoundsThiazoles

Autor:innen und Institutionen

  • From the Innovation Center for Neurological Disorders and Department of Neurology (H.L., X.H., P.W., W.S., C.X., B.W., S. Lv, C.W.), Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Ger…
  • Department of Radiology and Nuclear Medicine (Z.C., S.Y.), Xuanwu Hospital, Capital Medical University, Beijing, China.
  • College of Integrated Traditional Chinese and Western Medicine (J.G., S. Li), Changchun University of Chinese Medicine, Changchun, China.
  • School of Biological Science and Medical Engineering (R.L), Beihang University, Beijing, China.
  • Jinan Hospital of Xuanwu Hospital (C.W.), Shandong First Medical University, Jinan, China.

ORCID-Profile: Zhigeng Chen

Förderung

  • STI2030-Major Projects

Zitieren

APA

Luan, H., Chen, Z., Han, X., Wang, P., Sun, W., Gong, J., Li, S., Li, R., Xu, C., Wen, B., Lv, S., Yan, S., & Wei, C. (2026). Neuronal Surface and Intracellular Antibodies in Mild Cognitive Impairment Due to Alzheimer Disease: Preserved Brain Metabolism on 18 F-FDG-PET. American Journal of Neuroradiology. https://doi.org/10.3174/ajnr.a9159

Vancouver

Luan H, Chen Z, Han X, Wang P, Sun W, Gong J, et al. Neuronal Surface and Intracellular Antibodies in Mild Cognitive Impairment Due to Alzheimer Disease: Preserved Brain Metabolism on 18 F-FDG-PET. American Journal of Neuroradiology. 2026. doi:10.3174/ajnr.a9159

BibTeX
@article{Luan2026,
  author = {Luan, Heya and Chen, Zhigeng and Han, Xiaodong and Wang, Pin and Sun, Wenxian and Gong, Jin and Li, Shaoqi and Li, Ruina and Xu, Chang and Wen, Boye and Lv, Sirong and Yan, Shaozhen and Wei, Cuibai},
  title = {Neuronal Surface and Intracellular Antibodies in Mild Cognitive Impairment Due to Alzheimer Disease: Preserved Brain Metabolism on 18 F-FDG-PET},
  journal = {American Journal of Neuroradiology},
  year = {2026},
  doi = {10.3174/ajnr.a9159}
}
Kostenlos starten →